Nano-composite single grain YBa2Cu3O 7-δ/Y2Ba4CuBiOy bulk superconductors

We have succeeded recently in synthesizing a chemically stable, inert family of materials of composition Y2Ba4CuMOy (Y-2411 where M Nb, Ta, Mo, W, Zr, Hf) within the superconducting YBa 2Cu3O7-δ (Y-123) phase matrix that forms effective flux pinning centers of nano-scale dimensions. In this paper we report the synthesis of the Y2Ba4CuBiOy phase with nano-scale dimensions that is similarly compatible with the Y-123 matrix and which does not impair the properties of the bulk superconductor. YBa 2Cu3O7-δ/Y2BaCuO5 (Y-123/Y-211) precursor powders enriched with various amounts of Bi 2O3 and Y2Ba4CuBiOy have been fabricated successfully in the form of large, single grains by the top seeded melt growth (TSMG) process. Microstructural studies of these composites reveal the presence of nanometer-sized Y2Ba4CuBiO y and much larger Y-211 phase particles (∼1 νm) embedded in the Y-123 phase matrix. The critical current density of the nano-composites is observed to increase significantly compared to undoped YBCO. © 2006 IOP Publishing Ltd

Analysis of melt-textured YBCO with nanoscale inclusions

Recently, particles with the chemical composition Y2Ba 4CuMOx where M U, Nb, Zr, etc., and sizes in the range of 50 - 200 nm have been generated within the YBCO matrix of bulk, melt-processed superconductors in order to serve as effective flux pinning sites. By means of AFM and electron backscatter diffraction (EBSD) measurements, we analyse the spatial distribution and the size distribution of these nanoparticles within the superconducting YBCO matrix

Investigation of grain orientations of melt-textured HTSC with addition of uranium oxide, Y2O3 and Y2BaCuO5

Local grain orientations were studied in melt-textured YBCO samples processed with various amounts of depleted uranuim oxide (DU) and Y 2O3 by means of electron backscatter diffraction (EBSD) analysis. The addition of DU leads to the formation of Ucontaining nanoparticles (Y2Ba4CuUOx) with sizes of around 200 nm, embedded in the superconducting Y-123 matrix. The orientation of the Y 2BaCuO5 (Y-211) particles, which are also present in the YBCO bulk microstructure, is generally random as is the case in other melttextured Y-123 samples. The presence of Y-211 particles, however, also affects the orientation of the Y-123 matrix in these samples

In silico identification of potential inhibitors for human aurora kinase b

Cell cycle progression through mitosis and meiosis involves regulation by serine/threonine kinases from the aurora family. Aurora kinase b (Aurkb) is mainly involved in the proper segregation of chromosomes during mitosis as well as meiosis. However, over expression of Aurkb leads to the unequal distribution of genetic information creating aneuploid cells, a hallmark of cancer. Thus, Aurkb can be used as an effective molecular target for computer-aided drug discovery against cancer. Existing Aurkb inhibitors are less efficient, hence an in silico work was carried out to identify novel potent inhibitors. Three published inhibitors azd1152, zm447439 and N-(4-{[6-methoxy-7-(3-morpholin-4-ylpropoxy) quinazolin- 4-yl] amino} phenyl) benzamide were subjected to high throughput virtual screening of over 1 million entries from a ligand info meta database, to generate a 1161 compound library. The crystal structure was optimized and energy was minimized applying an OPLS force field in Maestro v9.0. Molecular docking using Glide was performed to predict the binding orientation of the prepared ligand molecule into a grid of 20*20*20 Å created around the centroid of the optimized human Aurkb protein. Nine lead molecules with good binding affinity with human Aurkb were identified. In silico pharmacokinetics study for these nine lead molecules has shown no ADME violation. Analysis of lead ‘1’- human Aurkb docking complex has revealed a XP Gscore of -10.20 kcal/mol with a highly stabilized hydrogen bond network with Asp218 and Ala157 and good Van der wall interactions. The docking complex coincides well with the native co- crystallized human Aurkb and inhibitor zm447439 complex. Thus, lead 1 would be highly useful for developing potential drug molecules for the treatment of cancer